Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anavex Life Sciences Corp AVXL

Healthcare Biotechnology
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more

Recent & Breaking News (NDAQ:AVXL)

Contact Levi & Korsinsky by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation (AVXL)

Accesswire March 26, 2024

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Anavex Life Sciences Corp. and Encourages Investors with Losses to Contact the Firm

Accesswire March 26, 2024

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm

Newsfile March 25, 2024

Levi & Korsinsky Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL

Accesswire March 25, 2024

AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors Can Join the Class Action Lawsuit!

Accesswire March 25, 2024

Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact Levi & Korsinsky

Accesswire March 25, 2024

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corp. (AVXL) Investors

Business Wire March 25, 2024

Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire March 25, 2024

Levi & Korsinsky Reminds Anavex Life Sciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL

Accesswire March 25, 2024

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Anavex Life Sciences Corp. and Encourages Investors with Losses to Contact the Firm

Accesswire March 25, 2024

Levi & Korsinsky Notifies Shareholders of Anavex Life Sciences Corporation(AVXL) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire March 24, 2024

Contact Levi & Korsinsky by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL)

Accesswire March 24, 2024

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Anavex Life Sciences Corp. and Encourages Investors with Losses to Contact the Firm

Accesswire March 24, 2024

AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors Can Join the Class Action Lawsuit!

Accesswire March 24, 2024

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders

Accesswire March 23, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex

Newsfile March 23, 2024

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Anavex Life Sciences Corp. and Encourages Investors with Losses to Contact the Firm

Accesswire March 23, 2024

AVXL INVESTOR ALERT: Anavex Life Sciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Newsfile March 22, 2024

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm

Newsfile March 22, 2024

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL

Accesswire March 22, 2024